Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 3Dermatologic 1

Conditions

Melanoma 4Sarcoma 1Glioblastoma 1Brain Neoplasms 1

Interventions

pembrolizumab 4Drug Therapy 3Temozolomide 2Radiation 2Paclitaxel 2Nivolumab 2Cisplatin 2Bevacizumab 2vocimagene amiretrorepvec 1ulixertinib 1temsirolimus 1selinexor 1rovalpituzumab tesirine 1regorafenib 1pazopanib 1niraparib 1imetelstat 1fludarabine 1erythromycin propionate-N-acetylcysteinate 1epacadostat 1efineptakin alfa 1durvalumab 1dostarlimab 1cobimetinib 1cediranib 1cc-486 1carboxyamido-triazole 1bemcentinib 1aflibercept 1WP1066 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioblastoma × Vaccines × Dermatologic × Clear all
NCT02431572 2020-04-28

A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy

Massachusetts General Hospital

Phase NA Completed
11 enrolled 8 charts
CNSDermatologic

Brain Neoplasms, Glioblastoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡